Well the market has spoken.
If we take the worst case scenario, ie full dilution of 35% the market values avx at 61c per share post phase IIb results.
Pre results but with the capital raising, ie pre result share price 68c, full dilution would have resulted in a share price of 44c.
The market has therefore valued the phase IIb results at 17c ps or a 38% increase.
Im not complaining… 38% increase is great…. However I would have thought it warranted more than that… given that prior to the successful results the company technically had nothing but hope, now they have a real drug with a very real probability of commercialization.
- Forums
- ASX - By Stock
- the market has spoken
Well the market has spoken.If we take the worst case scenario,...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online